Ascendiant Capital Maintains Buy on Surgepays, Raises Price Target to $3.75
Ascendiant Capital analyst Edward Woo maintains Surgepays (NASDAQ:SURG) with a Buy and raises the price target from $3.5 to $3.75.
Stocks · News reference
8-K filing — SurgePays, Inc. (SURG)
Filed: 2026-09-16 AccNo: 0001493152-26-042938 Size: 205 KB Item 4.01: Changes in Registrant's Certifying Accountant
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Why Scholar Rock Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Scholar Rock surged 11.9% after FDA approved ISEMBYLD for SMA; Scinai, Intercont and Rum led premarket gainers, while Picocela fell.
Why RH Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
RH shares jumped 8.2% premarket after EPS beat estimates despite a revenue miss; Oracle and others gained, while OPTT and ZUMZ fell.